16673-34-0
16673-34-0
Chemical Structure
NLRP3-IN-2
- CAS No.: 16673-34-0
- Formula:C16H17ClN2O4S
- Molecular Weight:368.84
IUPAC Name: 5-chloro-2-methoxy-N-(4-sulfamoylphenethyl)benzamide
InChIKey: KVWWTCSJLGHLRM-UHFFFAOYSA-N
SMILES: O=C(NCCC1=CC=C(S(=O)(N)=O)C=C1)C2=CC(Cl)=CC=C2OC
Biological Activity: NLRP3-IN-2, an intermediate substrate in the synthesis of glyburide, inhibits the formation of the NLRP3 inflammasome in cardiomyocytes and limits the infarct size following myocardial ischemia/reperfusion in the mouse, without affecting glucose metabolism[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
NLRP3-IN-2 | 98.00% | NLRP3-IN-2, an intermediate substrate in the synthesis of glyburide, inhibits the formation of the NLRP3 inflammasome in cardiomyocytes and limits the infarct size following myocardial ischemia/reperfusion in the mouse, without affecting glucose metabolism. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
NLRP3-IN-2 (Standard) | ≥98% | NLRP3-IN-2 (Standard) is the analytical standard of NLRP3-IN-2. This product is intended for research and analytical applications. NLRP3-IN-2, an intermediate substrate in the synthesis of glyburide, inhibits the formation of the NLRP3 inflammasome in cardiomyocytes and limits the infarct size following myocardial ischemia/reperfusion in the mouse, without affecting glucose metabolism. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
